The disease course and pathology of CD4-CKO and Akt3Nmf350 during acute disease points to the notion that Akt3 signaling in CD4+ T-cells may largely regulate preclinical T-cell responses. The gene discussed is CD4; the disease is glycogen storage disease VI.